ARCHIVES

Two Second-Line CML Drugs Work Front-Line, Studies Find

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

In Brief: John Young to Leave NCI for ELM; Yates Looking for Chief Of Outpatient Services At RPI

March 18, 1988

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

Hybridoma Cell Lines Available from NCI

September 3, 1982

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001